House of Lords Business
Show full summary

Baroness Merron to ask His Majesty's Government what assessment they have made of the cost of diagnosing and treating Growth Hormone Deficiency patients versus the cost of not doing so, given the costs arising from untreated patients including increased incidence of unemployment benefits and mental health treatments. 

Question HL5329: tabled on 1 February 2023 and due for answer by 15 February 2023

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Baroness Merron to ask His Majesty's Government what assessment they have made of the cost of diagnosing and treating Growth Hormone Deficiency patients versus the cost of not doing so, given the costs arising from untreated patients including increased incidence of unemployment benefits and mental health treatments.  HL5329
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Date Answered

Tuesday 14 February 2023

Member's Registered Interests

There are no interests to show.

Main Member

Baroness Merron
Labour
Life peer